Take a look at what’s clicking on FoxBusiness.com.
Hims & Hers Fitness introduced on Tuesday it’ll bind Wegovy with the telehealth platform’s club thru a untouched collaboration with drugmaker Novo Nordisk.
The bind will trade in Novo Nordisk’s frequent weight-loss drug in any respect its dosage strengths paired with a Hims & Hers club offering “access to 24/7 care, ongoing clinical support, and nutrition guidance,” Hims & Hers mentioned.
“We’re excited to work with Novo Nordisk, a company known for breakthrough innovation in clinical medicine and a strong portfolio of medications,” Hims & Hers CEO Andrew Dudum mentioned in a commentary. “We share a vision of what consumer-centered healthcare looks like, and this is just the first step towards delivering that future.”
Stocks of Hims & Hers jumped 25% at the information.
The bind will trade in Novo Nordisk’s frequent weight-loss drug in any respect its dosage strengths paired with a Hims & Hers club. (Piotr Swat/SOPA Photographs/LightRocket by the use of Getty Photographs / Getty Photographs)
It’ll lift a per 30 days $599 settingup price ticket. Novo Nordisk’s NovoCare Pharmacy, a direct-to-patient on-line pharmacy aimed toward cash-paying Wegovy sufferers that went are living terminating date, will probably be at once to be had during the telehealth corporate’s platform as a part of the partnership.
NOVO NORDISK CUTS WEGOVY PRICES IN HALF FOR CASH-PAYING CONSUMERS
Hims & Hers and Novo Nordisk will foundation the bind at the telehealth corporate’s platform this time.
It “builds on Hims & Hers’ existing suite of weight loss solutions and provides access to all dose strengths of Wegovy in a high-quality pen for self-pay patients,” Hims & Hers mentioned.
Hims & Hers and Novo Nordisk will foundation the bind at the telehealth corporate’s platform this time. (Michael Siluk/UCG/Common Photographs Team by the use of Getty Photographs / Getty Photographs)
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Along with the bind, Hims & Hers mentioned the 2 firms are within the strategy of devising a roadmap that mixes the Danish drugmaker’s “innovative treatments” with the telehealth platform’s “ability to scale access to quality care.”
Novo Nordisk in Copenhagen, Denmark. (REUTERS/Tom Negligible/Document picture / Reuters Pictures)
Two alternative telehealth firms, Ro and Future MD, in a similar fashion unveiled partnerships with Novo Nordisk on Tuesday that may contain integrating NovoCare Pharmacy into their platforms and providing Wegovy.
OZEMPIC, WEGOVY AMONG DRUGS SUBJECT TO MEDICARE PRICE CONTROLS
Wegovy is one among a number of GLP-1 recoveries that experience change into extraordinarily frequent for weight reduction lately, together with Novo’s Ozempic and Eli Lilly’s Zepbound and Mounjaro.
| Ticker | Safety | Extreme | Alternate | Alternate % |
|---|---|---|---|---|
| HIMS | HIMS & HERS HEALTH | 34.61 | +6.13 | +21.52% |
| NVO | NOVO NORDISK A/S | 62.62 | +0.54 | +0.87% |
